MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
10.77
+0.11 (1.03%)
Jul 20, 2026, 4:00 PM EDT - Market closed
MiNK Therapeutics Market Cap
MiNK Therapeutics has a market cap or net worth of $53.66 million as of July 20, 2026. Its market cap has decreased by -33.72% in one year.
Market Cap
53.66M
Enterprise Value
43.13M
1-Year Change
-33.72%
Ranking
Category
Stock Price
$10.77
ChartMarket Cap Chart
Since the IPO on October 15, 2021, MiNK Therapeutics's market cap has decreased from $386.36M to $53.66M, a decrease of -86.11%. That is a compound annual growth rate of -33.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 53.66M | 2.51% |
| Dec 31, 2025 | 52.34M | 89.51% |
| Dec 31, 2024 | 27.62M | -25.23% |
| Dec 29, 2023 | 36.94M | -58.11% |
| Dec 30, 2022 | 88.18M | -40.99% |
| Dec 31, 2021 | 149.43M | -61.32% |
| Oct 15, 2021 | 386.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cardiff Oncology | 56.75M |
| Context Therapeutics | 56.02M |
| Boundless Bio | 55.60M |
| Edesa Biotech | 54.51M |
| INmune Bio | 54.50M |
| Veraxa Biotech AG | 54.09M |
| Xilio Therapeutics | 52.35M |
| Immutep | 51.45M |